The frequency of human papilloma virus types 16, 18 in upper genital tract of women at high risk of developing ovarian cancer

O. O. Bilyk, N. T. Pande, Tanja Pejovic, L. G. Buchynska

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aim: To investigate the incidence of human papilloma virus (HPV) types 16, 18 in upper genital tract of women considered at a high risk (HR) of developing epithelial ovarian cancer (EOC). Methods: HPV 16 and 18 E6 ORF specific semiquantitative PCR was used to screen the incidence of HPV in 20 women at HR of developing EOC and 10 women with no ovarian disease (control). Results: The HR subset of fallopian tubes and ovarian tissues showed greater positivity for HPV E6 ORF (40%) as compared to control (10%) tissues. Of all the samples, two (10%) were positive for HPV 16, two (10%) were positive for HPV 18, and four (20%) showed positivity for mixed HPV 16/18 infection. The presence of HPV E6 ORF was found both in the fallopian tubes and ovarian DNA from 6 (30%) patients. In two cases (10%) we detected HPV ORF only in the fallopian tube derived genomic DNA. Conclusion: It has been shown the presence of HPV in the upper genital tract in women at HR of developing EOC in close proximity of HPV susceptible tissue cervix.

Original languageEnglish (US)
Pages (from-to)121-124
Number of pages4
JournalExperimental Oncology
Volume36
Issue number2
StatePublished - 2014

Fingerprint

Papillomaviridae
Ovarian Neoplasms
Open Reading Frames
Fallopian Tubes
Ovarian Diseases
DNA
Incidence

Keywords

  • High risk of ovarian cancer
  • HPV

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

The frequency of human papilloma virus types 16, 18 in upper genital tract of women at high risk of developing ovarian cancer. / Bilyk, O. O.; Pande, N. T.; Pejovic, Tanja; Buchynska, L. G.

In: Experimental Oncology, Vol. 36, No. 2, 2014, p. 121-124.

Research output: Contribution to journalArticle

@article{423d4f47b10b411096540fce046e6adb,
title = "The frequency of human papilloma virus types 16, 18 in upper genital tract of women at high risk of developing ovarian cancer",
abstract = "Aim: To investigate the incidence of human papilloma virus (HPV) types 16, 18 in upper genital tract of women considered at a high risk (HR) of developing epithelial ovarian cancer (EOC). Methods: HPV 16 and 18 E6 ORF specific semiquantitative PCR was used to screen the incidence of HPV in 20 women at HR of developing EOC and 10 women with no ovarian disease (control). Results: The HR subset of fallopian tubes and ovarian tissues showed greater positivity for HPV E6 ORF (40{\%}) as compared to control (10{\%}) tissues. Of all the samples, two (10{\%}) were positive for HPV 16, two (10{\%}) were positive for HPV 18, and four (20{\%}) showed positivity for mixed HPV 16/18 infection. The presence of HPV E6 ORF was found both in the fallopian tubes and ovarian DNA from 6 (30{\%}) patients. In two cases (10{\%}) we detected HPV ORF only in the fallopian tube derived genomic DNA. Conclusion: It has been shown the presence of HPV in the upper genital tract in women at HR of developing EOC in close proximity of HPV susceptible tissue cervix.",
keywords = "High risk of ovarian cancer, HPV",
author = "Bilyk, {O. O.} and Pande, {N. T.} and Tanja Pejovic and Buchynska, {L. G.}",
year = "2014",
language = "English (US)",
volume = "36",
pages = "121--124",
journal = "Experimental Oncology",
issn = "1812-9269",
publisher = "Morion LLC",
number = "2",

}

TY - JOUR

T1 - The frequency of human papilloma virus types 16, 18 in upper genital tract of women at high risk of developing ovarian cancer

AU - Bilyk, O. O.

AU - Pande, N. T.

AU - Pejovic, Tanja

AU - Buchynska, L. G.

PY - 2014

Y1 - 2014

N2 - Aim: To investigate the incidence of human papilloma virus (HPV) types 16, 18 in upper genital tract of women considered at a high risk (HR) of developing epithelial ovarian cancer (EOC). Methods: HPV 16 and 18 E6 ORF specific semiquantitative PCR was used to screen the incidence of HPV in 20 women at HR of developing EOC and 10 women with no ovarian disease (control). Results: The HR subset of fallopian tubes and ovarian tissues showed greater positivity for HPV E6 ORF (40%) as compared to control (10%) tissues. Of all the samples, two (10%) were positive for HPV 16, two (10%) were positive for HPV 18, and four (20%) showed positivity for mixed HPV 16/18 infection. The presence of HPV E6 ORF was found both in the fallopian tubes and ovarian DNA from 6 (30%) patients. In two cases (10%) we detected HPV ORF only in the fallopian tube derived genomic DNA. Conclusion: It has been shown the presence of HPV in the upper genital tract in women at HR of developing EOC in close proximity of HPV susceptible tissue cervix.

AB - Aim: To investigate the incidence of human papilloma virus (HPV) types 16, 18 in upper genital tract of women considered at a high risk (HR) of developing epithelial ovarian cancer (EOC). Methods: HPV 16 and 18 E6 ORF specific semiquantitative PCR was used to screen the incidence of HPV in 20 women at HR of developing EOC and 10 women with no ovarian disease (control). Results: The HR subset of fallopian tubes and ovarian tissues showed greater positivity for HPV E6 ORF (40%) as compared to control (10%) tissues. Of all the samples, two (10%) were positive for HPV 16, two (10%) were positive for HPV 18, and four (20%) showed positivity for mixed HPV 16/18 infection. The presence of HPV E6 ORF was found both in the fallopian tubes and ovarian DNA from 6 (30%) patients. In two cases (10%) we detected HPV ORF only in the fallopian tube derived genomic DNA. Conclusion: It has been shown the presence of HPV in the upper genital tract in women at HR of developing EOC in close proximity of HPV susceptible tissue cervix.

KW - High risk of ovarian cancer

KW - HPV

UR - http://www.scopus.com/inward/record.url?scp=84903775645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903775645&partnerID=8YFLogxK

M3 - Article

C2 - 24980768

AN - SCOPUS:84903775645

VL - 36

SP - 121

EP - 124

JO - Experimental Oncology

JF - Experimental Oncology

SN - 1812-9269

IS - 2

ER -